Advertisement

Related Videos

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Victoria T. Brown, PharmD, BCOP, on Payer Intervention: The Example of Abiraterone

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Advertisement

Advertisement




Apr
14
Today In Oncology
James P. Allison, PhD, Honored With the 2026 AACR Award for Lifetime Achievement in Cancer Research
Electroacupuncture Relieves Cognitive Psychological Symptoms in Breast Cancer Survivors in Pilot Study
Elinzanetant May Reduce Side Effects of Endocrine Therapy Among Patients With Breast Cancer
POSITIVE Trial Update: Oncologic Outcomes Maintained After Pausing Endocrine Therapy for Pregnancy
Analysis of Constitutional Cancer Predisposition Gene Variants in Nearly 15,000 Patients
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo